Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
Public ClinicalTrials.gov record NCT05509023. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Phase 2a Proof-of-Concept Study Evaluating the Safety and Efficacy of ADX-914 in Subjects With Moderate to Severe Atopic Dermatitis
Study identification
- NCT ID
- NCT05509023
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Q32 Bio Inc.
- Industry
- Enrollment
- 102 participants
Conditions and interventions
Conditions
Interventions
- ADX-914 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 29, 2022
- Primary completion
- Nov 30, 2024
- Completion
- Nov 30, 2024
- Last update posted
- Oct 2, 2024
2022 – 2024
United States locations
- U.S. sites
- 24
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Dermatology Skin Health Center | Birmingham | Alabama | 35244 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| California Allergy and Asthma Medical Group- Los Angeles | Los Angeles | California | 90025 | — |
| Integrative Skin Science and Research | Sacramento | California | 95815 | — |
| Dermatology Institute and Skin Care Center | Santa Monica | California | 90404 | — |
| Torrance Clinical Research Institute Inc. | Torrance | California | 90505 | — |
| Integrated Research of Inland, Inc. | Upland | California | 91786 | — |
| RM Medical Research Inc. | Homestead | Florida | 33175 | — |
| Medical Research Center of Miami | Miami | Florida | 33134 | — |
| Well Pharma Medical Research Corporation | Miami | Florida | 33173 | — |
| GCP Research | St. Petersburg | Florida | 33705 | — |
| Advanced Medical Research, PC | Sandy Springs | Georgia | 30328 | — |
| Treasure Valley Medical Research | Boise | Idaho | 83706 | — |
| Sneeze wheeze and Itch Associates LLC | Normal | Illinois | 61761 | — |
| Southern Indiana Clinical Trials | New Albany | Indiana | 47150 | — |
| Visage Clinical Research | Largo | Maryland | 20774 | — |
| Revival Research Corporation- Clinedge | Troy | Michigan | 48084 | — |
| Apex Clinical Research Center | Painesville | Ohio | 33612 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| North Texas Center for Clinical Research | Frisco | Texas | 75034 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| JBR Clinical Research | Salt Lake City | Utah | 84107 | — |
| Dermatology of Seattle & Bellevue | Seattle | Washington | 98004 | — |
| Dermatology Specialists of Spokane | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05509023, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 2, 2024 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05509023 live on ClinicalTrials.gov.